Matches in Wikidata for { <http://www.wikidata.org/entity/Q64171346> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q64171346 description "clinical trial" @default.
- Q64171346 description "ensayu clínicu" @default.
- Q64171346 description "klinisch onderzoek" @default.
- Q64171346 description "клінічне випробування" @default.
- Q64171346 name "Durvalumab and Tremelimumab for Pediatric Malignancies" @default.
- Q64171346 type Item @default.
- Q64171346 label "Durvalumab and Tremelimumab for Pediatric Malignancies" @default.
- Q64171346 prefLabel "Durvalumab and Tremelimumab for Pediatric Malignancies" @default.
- Q64171346 P1132 Q64171346-9F582035-0B2B-4C89-A02A-DA2E755F5B2B @default.
- Q64171346 P1476 Q64171346-E65D513F-8DFB-45C2-A5AB-A559B96218F2 @default.
- Q64171346 P17 Q64171346-2E685956-2440-4B1B-86E3-2C9E7B1E5502 @default.
- Q64171346 P17 Q64171346-4A09B575-1EE8-4568-A509-B4563160A80C @default.
- Q64171346 P17 Q64171346-67134BE3-F028-411A-9907-06C3BE626327 @default.
- Q64171346 P17 Q64171346-A1A37096-3A4F-4295-B620-50FC18CCCB5E @default.
- Q64171346 P17 Q64171346-AF635717-092D-448D-8418-F6F2AF4380A9 @default.
- Q64171346 P17 Q64171346-F303BC08-E4B6-40BC-9326-66DB235A9DBF @default.
- Q64171346 P3098 Q64171346-0A5035D2-DF28-4DB0-937E-A1E70A5E1A10 @default.
- Q64171346 P31 Q64171346-5E143602-541E-42E9-AF1F-E9A136C4007E @default.
- Q64171346 P4135 Q64171346-7C823CCF-49F3-44F4-B46D-2451C86886CD @default.
- Q64171346 P580 Q64171346-0534169E-A6E3-40D1-8C39-17F9B433B28F @default.
- Q64171346 P582 Q64171346-72D9B21F-CD9D-433F-8353-4507F79B9DED @default.
- Q64171346 P6099 Q64171346-0CD14706-82A8-42A5-BDF9-A25A486240E2 @default.
- Q64171346 P6099 Q64171346-D1C27C01-4609-47EB-85BD-495B8F06C4EB @default.
- Q64171346 P8363 Q64171346-1E3479D8-220D-42A3-B472-4BD40A2CE527 @default.
- Q64171346 P1132 "+158" @default.
- Q64171346 P1476 "Phase I/II, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Durvalumab Monotherapy or in Combination With Tremelimumab in Pediatric Patients With Advanced Solid Tumors and Hematological Malignancies" @default.
- Q64171346 P17 Q142 @default.
- Q64171346 P17 Q145 @default.
- Q64171346 P17 Q183 @default.
- Q64171346 P17 Q30 @default.
- Q64171346 P17 Q38 @default.
- Q64171346 P17 Q55 @default.
- Q64171346 P3098 "NCT03837899" @default.
- Q64171346 P31 Q30612 @default.
- Q64171346 P4135 "+17" @default.
- Q64171346 P580 "2019-03-07T00:00:00Z" @default.
- Q64171346 P582 "2021-10-18T00:00:00Z" @default.
- Q64171346 P6099 Q42824440 @default.
- Q64171346 P6099 Q5452194 @default.
- Q64171346 P8363 Q78089383 @default.